• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort.

作者信息

Barreiro-de Acosta M, Gisbert J P

机构信息

Department of Gastroenterology, Hospital Clínico Universitario de Santiago de Compostela, Santiago, Spain.

Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.

出版信息

Aliment Pharmacol Ther. 2017 Mar;45(6):855-856. doi: 10.1111/apt.13929.

DOI:10.1111/apt.13929
PMID:28211628
Abstract
摘要

相似文献

1
Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort.
Aliment Pharmacol Ther. 2017 Mar;45(6):855-856. doi: 10.1111/apt.13929.
2
Editorial: relative efficacy of infliximab and adalimumab in Crohn's disease in an Australian and New Zealand cohort - authors' reply.
Aliment Pharmacol Ther. 2017 Mar;45(6):856-857. doi: 10.1111/apt.13968.
3
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study.英夫利昔单抗与阿达木单抗治疗克罗恩病的比较：澳大利亚和新西兰一项观察性队列研究中327例患者的结果
Aliment Pharmacol Ther. 2017 Feb;45(4):542-552. doi: 10.1111/apt.13880. Epub 2016 Dec 19.
4
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.用于维持克罗恩病缓解的肿瘤坏死因子-α抗体。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD006893. doi: 10.1002/14651858.CD006893.
5
Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.英夫利昔单抗和阿达木单抗诱发一名患有结肠克罗恩病女性的血小板减少症。
Gut. 2007 Aug;56(8):1169-70. doi: 10.1136/gut.2007.123547. Epub 2007 Mar 7.
6
Local injection of adalimumab for perianal Crohn's disease: better than infliximab?阿达木单抗局部注射治疗肛周克罗恩病：是否优于英夫利昔单抗？
Inflamm Bowel Dis. 2010 Oct;16(10):1631. doi: 10.1002/ibd.21210.
7
Editorial: adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.
Aliment Pharmacol Ther. 2017 Jan;45(1):178-179. doi: 10.1111/apt.13842.
8
Adalimumab for Crohn's disease after infliximab treatment failure: a systematic review.阿达木单抗治疗英夫利昔单抗治疗失败的克罗恩病：系统评价。
Eur J Gastroenterol Hepatol. 2013 Aug;25(8):885-91. doi: 10.1097/MEG.0b013e32836220ab.
9
Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: a real life cohort study.与英夫利昔单抗相比，接受阿达木单抗治疗的克罗恩病门诊患者出现继发性反应丧失和需要增加剂量的时间更早：一项真实队列研究。
J Crohns Colitis. 2014 Nov;8(11):1454-63. doi: 10.1016/j.crohns.2014.05.007. Epub 2014 Jun 16.
10
Editorial: first among Equals-not for either infliximab or adalimumab in Crohn's disease-yet.社论：在克罗恩病的治疗中，英夫利昔单抗和阿达木单抗目前都还称不上是“平等中的首位” 。
Aliment Pharmacol Ther. 2018 Apr;47(8):1225-1226. doi: 10.1111/apt.14549.

引用本文的文献

1
Acute pancreatitis as an initial presentation of Crohn's disease: A case report.以急性胰腺炎为首发表现的克罗恩病：一例报告
J Family Med Prim Care. 2019 Nov 15;8(11):3752-3754. doi: 10.4103/jfmpc.jfmpc_753_19. eCollection 2019 Nov.